Asha S. Nayar

462 citations
7 papers · 386 indexed · h-index 7
Topics
Antibiotic Resistance in Bacteria (6 papers)Bacterial Genetics and Biotechnology (3 papers)Cancer therapeutics and mechanisms (2 papers)

In The Last Decade

Asha S. Nayar

7 papers receiving 372 citations

Peers

Asha S. Nayar
Comparison fields: 5 of 57
  • Molecular Biology 230
  • Molecular Medicine 210
  • Genetics 104
  • Pharmacology 79
  • Ecology 68
Replace Maxim S. Svetlov with:
Maxim S. Svetlov United States
Karanbir S. Pahil United States
Karen O’Dwyer United States
Carmen DeMarco United States
Steven M. Crespo‐Carbone United States
Alexandre Famechon France
Christopher E. Morgan United States
Sang Kyun Ahn Canada
Beatriz Llano-Sotelo United States
Marjorie H. Barnes United States
Asha S. Nayar relative to Maxim S. Svetlov United States Maxim S. Svetlov's profile →
Citations per field
00.5×5.3×
Maxim S. Svetlov · 1×
Citations per year

Countries citing papers authored by Asha S. Nayar

Since Specialization
Citations

This map shows the geographic impact of Asha S. Nayar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asha S. Nayar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asha S. Nayar more than expected).

Fields of papers citing papers by Asha S. Nayar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asha S. Nayar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asha S. Nayar. The network helps show where Asha S. Nayar may publish in the future.

Co-authorship network of co-authors of Asha S. Nayar

This figure shows the co-authorship network connecting the top 25 collaborators of Asha S. Nayar. A scholar is included among the top collaborators of Asha S. Nayar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asha S. Nayar. Asha S. Nayar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 52
2 58
3 90
4 66
5 21
6 38
7 61

About Asha S. Nayar

Asha S. Nayar is a scholar working on Molecular Medicine, Clinical Biochemistry and Pharmacology, having authored 7 papers that have together received 386 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Bacterial Genetics and Biotechnology (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Molecular Medicine (210 citations), Applied Microbiology and Biotechnology (11 citations) and Microbiology (29 citations). Asha S. Nayar has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Alita A. Miller, Vincent M. Isabella, Thomas J. Dougherty, Keith Ferguson, Sean M. Callahan, Douglas D. Risser, Ramya Rajagopalan, David E. Ehmann, Ying Zhou and Lindsey Leach. Their work appears in journals such as Analytical Chemistry, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026